Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2846.2000 -10.80 (-0.38%)
NSE Jun 06, 2025 15:31 PM
Volume: 76,490
 

2846.20
-0.38%
ICICI Securities Limited
Dr Lal PathLabs’ (Dr Lal) Q1FY25 result was in line with our expectations. Growth was driven by better uptick in Swasthfit (up 26.4% YoY) overall sample volume rose 9.3% YoY.
Dr. Lal Pathlabs Ltd. has an average target of 2992.60 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended